Carcinoid Tumors
📧 Sign up to get email alerts when something new happens for Carcinoid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety of 68Ga-DOTA-tyr3-Octreotide PET in diagnosing solid tumors has completed with posted results…
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating Ga-68 DOTATOC PET-CT imaging in the management of neuroendocrine tumors has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors [Phase 2]
Phase II study of ibrutinib in advanced carcinoid and pancreatic neuroendocrine tumors has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors [Phase 2]
Phase II study of pertuzumab in combination with erlotinib for metastatic or unresectable neuroendocrine tumors was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors [Phase 2]
A Phase 2 study evaluating SOM230 (pasireotide) in patients with metastatic carcinoid tumors has completed and results were posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.